Detection of proximal colorectal cancers through analysis of faecal DNA
- PMID: 11844514
- DOI: 10.1016/S0140-6736(02)07591-8
Detection of proximal colorectal cancers through analysis of faecal DNA
Abstract
Detection of mutations in faecal DNA represents a promising, non-invasive approach for detecting colorectal cancers in average-risk populations. One of the first practical applications of this technology involves the examination of microsatellite markers in sporadic cancers with mismatch-repair deficiencies. Since such cancers nearly always occur in the proximal colon, this test might be useful as an adjunct to sigmoidoscopy, which detects only distal colorectal lesions. We report here the first in-depth analysis of faecal DNA from patients with proximal cancers to determine the feasibility, sensitivity, and specificity of this approach. Using a sensitive method for microsatellite mutation detection, we found that 18 of 46 cancers had microsatellite alterations and that identical mutations could be identified in the faecal DNA of 17 of these 18 cases.
Similar articles
-
Detection of APC mutations in fecal DNA from patients with colorectal tumors.N Engl J Med. 2002 Jan 31;346(5):311-20. doi: 10.1056/NEJMoa012294. N Engl J Med. 2002. PMID: 11821507
-
Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.Gut. 2005 Feb;54(2):264-7. doi: 10.1136/gut.2004.048132. Gut. 2005. PMID: 15647192 Free PMC article.
-
[A double immunochemical method for detecting faecal haemoglobin and albumin in rectal screening].Magy Onkol. 2011 Nov;55(4):268-73. Epub 2011 Aug 25. Magy Onkol. 2011. PMID: 22128309 Hungarian.
-
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.Cancer Res. 1998 Nov 15;58(22):5248-57. Cancer Res. 1998. PMID: 9823339 Review.
-
Clinicopathologic features in colorectal cancer patients with microsatellite instability.Mutat Res. 2004 Dec 21;568(2):275-82. doi: 10.1016/j.mrfmmm.2004.05.025. Mutat Res. 2004. PMID: 15542114 Review.
Cited by
-
Plasma Circulating mRNA Profile for the Non-Invasive Diagnosis of Colorectal Cancer Using NanoString Technologies.Int J Mol Sci. 2024 Mar 5;25(5):3012. doi: 10.3390/ijms25053012. Int J Mol Sci. 2024. PMID: 38474258 Free PMC article.
-
Effect of eriodictyol on preneoplastic lesions, oxidative stress and bacterial enzymes in 1,2-dimethyl hydrazine-induced colon carcinogenesis.Toxicol Res (Camb). 2017 Jun 19;6(5):678-692. doi: 10.1039/c7tx00074j. eCollection 2017 Sep 1. Toxicol Res (Camb). 2017. PMID: 30090535 Free PMC article.
-
Hotspot KRAS exon 2 mutations in CD166 positive colorectal cancer and colorectal adenoma cells.Oncotarget. 2018 Apr 17;9(29):20426-20438. doi: 10.18632/oncotarget.24921. eCollection 2018 Apr 17. Oncotarget. 2018. PMID: 29755662 Free PMC article.
-
Chemopreventive effect of myrtenal on bacterial enzyme activity and the development of 1,2-dimethyl hydrazine-induced aberrant crypt foci in Wistar Rats.J Food Drug Anal. 2016 Jan;24(1):206-213. doi: 10.1016/j.jfda.2015.07.003. Epub 2015 Dec 11. J Food Drug Anal. 2016. PMID: 28911405 Free PMC article.
-
Highly sensitive, non-invasive detection of colorectal cancer mutations using single molecule, third generation sequencing.Appl Transl Genom. 2015 Oct 16;7:32-9. doi: 10.1016/j.atg.2015.08.006. eCollection 2015 Dec. Appl Transl Genom. 2015. PMID: 27054083 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
